Synarel Nasal Spray, Solution 200Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Synarel: Nasal spray, solution (200mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

NAFARELIN (naf A re lin) is a man-made hormone that is like a hormone made in the body. It will lower the amount of testosterone in males and estrogen in females. It is used to treat endometriosis. This medicine is also used to diagnose and to treat precocious puberty.

In-Depth Information

Synarel 200mcg/actuation Nasal Spray

NDC: 000250166
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Precocious Puberty, Endometriosis

Sometimes used for but not FDA approved for the following conditions:
Uterine Leiomyomata, Infertility, Hirsutism

Storage Information
Protect from light
Store upright
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Synarel 200mcg/actuation Nasal Spray

Reported Side Effects for Synarel 200mcg/actuation Nasal Spray

Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Depression Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Eye Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Increased Sexual Desire Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Dandruff Incidence:
3.0-8.0%*
Severity: MILD
Onset: DELAYED
Vaginal Discharge Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Hot Flashes Incidence:
3.0-90.0%*
Severity: MODERATE
Onset: EARLY
Hirsutism Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Drug-induced Body Odor Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Emotional Lability Incidence:
6.0-16.0%*
Severity: MILD
Onset: EARLY
Increased Blood Fats Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Bleeding Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Increase In Breast Size Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Acne Incidence:
10.0-13.0%*
Severity: MILD
Onset: DELAYED
Nasal Irritation Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
High Triglycerides Incidence:
12.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
19.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
21.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Synarel

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5